Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, China.
Tissue Eng Part A. 2010 May;16(5):1549-58. doi: 10.1089/ten.TEA.2009.0529.
Stem cells have recently been isolated from humans and mice but not from rat tendon tissue. This study reports the isolation and characterization of stem cells from rat tendon. Nucleated cells isolated from rat flexor tendon tissues after collagenase digestion were plated at a low cell density to allow the selective proliferation of tendon-derived stem cells. About 1-2% of the cells isolated under this optimized culturing condition showed clonogenicity, high proliferative potential at low seeding density, and osteogenic, chondrogenic, and adipogenic multidifferentiation potential. These cells were CD44(+), CD90(+), CD34(-), and CD31(-). Although they shared some common properties with mesenchymal stem cells, they also exhibited their unique characteristics by expressing tenogenic and chondrogenic markers. There was expression of tenogenic markers, including alpha-smooth muscle actin, tenascin C, and tenomodulin, but not collagen type I at passage 0 (P0) and P3. Expression of a chondrogenic marker, aggrecan, was observed at P0 and P3, whereas expression of collagen type II was observed in few cells only at P3. The successful isolation of tendon-derived stem cells under the optimized growth and differentiation conditions was useful for future stem-cell-based tissue regenerative studies as well as studies on their roles in tendon physiology, healing, and disorders using the rat model.
干细胞最近已从人类和小鼠中分离出来,但尚未从大鼠肌腱组织中分离出来。本研究报告了从大鼠肌腱中分离和鉴定干细胞。胶原酶消化后从大鼠屈肌腱组织中分离出有核细胞,以较低的细胞密度接种,以允许肌腱来源的干细胞选择性增殖。在这种优化的培养条件下分离的细胞中,约有 1-2%表现出克隆形成能力、低接种密度下的高增殖潜能,以及成骨、软骨和成脂多向分化潜能。这些细胞 CD44(+)、CD90(+)、CD34(-)和 CD31(-)。虽然它们与间充质干细胞具有一些共同特性,但它们通过表达腱形成和软骨形成标志物也表现出其独特的特性。在 P0 和 P3 时表达腱形成标志物,包括α-平滑肌肌动蛋白、腱糖蛋白 C 和腱调蛋白,但不表达 I 型胶原。在 P0 和 P3 时观察到软骨形成标志物聚集蛋白聚糖的表达,而仅在 P3 时少数细胞中观察到 II 型胶原的表达。在优化的生长和分化条件下成功分离出肌腱来源的干细胞,这对于未来基于干细胞的组织再生研究以及使用大鼠模型研究其在肌腱生理学、愈合和疾病中的作用非常有用。
Tissue Eng Part A. 2010-5
Exp Dermatol. 2008-11
Tissue Eng Part A. 2010-5
J Musculoskelet Neuronal Interact. 2025-3-1
ACS Appl Bio Mater. 2025-3-17
Int J Mol Sci. 2024-11-1
Front Bioeng Biotechnol. 2024-8-8
BMC Musculoskelet Disord. 2024-7-19